Trial intelligence / Profile preview

Ondansetron vs metoclopramide vs placebo for emergency department nausea

ACTRN12609000549224Phase 4Not yet recruiting

Sponsor
Monash Medical Centre
Start
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in nausea ((none)) and Vomiting comparing Ondansetron, Metoclopramide and Placebo (3 arms). Primary endpoint: Clinically significant reduction in nausea. Planned start Aug 2009; status: not yet recruiting.

02

Drugs

ondansetronmetoclopramide
03

Conditions

nausea ((none))Vomiting

Beyond the preview

Go deeper on ACTRN12609000549224.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12609000549224.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call